PALISADE CAPITAL MANAGEMENT, LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 21 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,765,625
+4.1%
1,000,0000.0%0.05%
+8.9%
Q2 2023$1,696,250
-57.5%
1,000,000
-51.2%
0.04%
-58.3%
Q1 2023$3,989,195
+4.1%
2,051,0000.0%0.11%
+4.9%
Q4 2022$3,832,088
-41.2%
2,051,000
-46.5%
0.10%
-44.3%
Q3 2022$6,522,000
+63.9%
3,831,000
+21.4%
0.18%
+71.3%
Q2 2022$3,980,000
-4.4%
3,156,0000.0%0.11%
+12.5%
Q1 2022$4,163,000
-11.9%
3,156,000
-1.9%
0.10%0.0%
Q4 2021$4,726,000
+1.3%
3,218,000
+2.2%
0.10%
-5.9%
Q3 2021$4,666,000
+1.8%
3,148,000
-9.3%
0.10%
-1.0%
Q2 2021$4,584,000
-1.4%
3,469,000
-2.1%
0.10%
-5.5%
Q1 2021$4,649,000
-41.5%
3,542,000
+9.3%
0.11%
-46.3%
Q4 2020$7,951,000
+18.6%
3,242,0000.0%0.20%
+2.0%
Q3 2020$6,705,000
-12.5%
3,242,000
-2.8%
0.20%
-18.4%
Q2 2020$7,663,000
+68.1%
3,335,000
+15.6%
0.24%
+51.6%
Q1 2020$4,558,000
-18.8%
2,885,0000.0%0.16%
+1.3%
Q4 2019$5,611,000
+35.4%
2,885,000
-8.0%
0.16%
+25.2%
Q3 2019$4,144,000
-27.9%
3,135,000
+21.3%
0.13%
-28.7%
Q2 2019$5,751,000
+23.3%
2,585,0000.0%0.18%
+18.7%
Q1 2019$4,666,0002,585,0000.15%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders